SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001385508-21-000035
Filing Date
2021-03-04
Accepted
2021-03-04 16:09:31
Documents
85
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K opnt-20201231.htm   iXBRL 10-K 1869250
2 EX-31.1 opnt12312020exhibit311.htm EX-31.1 11477
3 EX-31.2 opnt12312020exhibit312.htm EX-31.2 13336
4 EX-32.1 opnt12312020exhibit321.htm EX-32.1 7743
5 EX-32.2 opnt12312020exhibit322.htm EX-32.2 7381
6 EX-23.1 opntconsent231.htm EX-23.1 2787
7 EX-4.2 exhibit42.htm EX-4.2 19590
  Complete submission text file 0001385508-21-000035.txt   7544613

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20201231.xsd EX-101.SCH 59224
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opnt-20201231_cal.xml EX-101.CAL 76629
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20201231_def.xml EX-101.DEF 328214
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20201231_lab.xml EX-101.LAB 668388
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20201231_pre.xml EX-101.PRE 474854
13 EXTRACTED XBRL INSTANCE DOCUMENT opnt-20201231_htm.xml XML 954801
Mailing Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38193 | Film No.: 21714230
SIC: 2834 Pharmaceutical Preparations